What was measured: The proportion of women with type 1 diabetes who were taking the recommended 5mg dose of folic acid prior to pregnancy.
Data collection end: December 2015
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: The proportion of women with type 2 diabetes who were taking the recommended 5mg dose of folic acid prior to pregnancy.
Data collection end: December 2015
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: The proportion of women with type 1 diabetes who were taking the recommended 5mg dose of folic acid prior to pregnancy.
Data collection end: December 2014
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes prescribed 5 mg/day folic acid from at least 3 months before conception.
Data collection end: December 2014
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who have a first trimester HbA1c level of <48mmol/mol.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who have a first trimester HbA1c level of <48mmol/mol.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who have a first trimester HbA1c level of >86mmol/mol.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who have a first trimester HbA1c level of >86mmol/mol.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who were taking insulin and metformin only prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who were taking insulin and metformin only prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who were taking metformin only prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who were taking metformin only prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who were taking diabetic medications other than metformin or insulin prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who were taking an ACE inhibitor or ARB prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who were taking an ACE inhibitor or ARB prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who were taking a statin prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who were taking a statin prior to pregnancy.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes with a HbA1c <48mmol/mol in late pregnancy (24 weeks+).
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes with a HbA1c <48mmol/mol in late pregnancy (24 weeks+).
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 1 diabetes who had contact with the joint diabetes antenatal team before 10+0 weeks gestation.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of pregnant women with type 2 diabetes who had contact with the joint diabetes antenatal team before 10+0 weeks gestation.
Data collection end: December 2016
Area covered: |
England and Wales |
Source: |
NHS Digital. National Pregnancy in Diabetes Audit.
|
What was measured: Proportion of women with diabetes, who had experienced an intrapartum stillbirth or intrapartum-related neonatal death and were managed in a joint diabetes and antenatal clinic in accordance with NICE guidance.
Data collection end: December 2015
Number that met the criteria: 4 / 8
Area covered: |
UK |
Source: |
Maternal, Newborn and Infant Clinical Outcome Review Programme. Perinatal Confidential Enquiry. |
What was measured: Proportion of women with diabetes that had their capillary plasma glucose monitored every hour during labour and birth.
Data collection end: June 2015
Area covered: |
UK |
Source: |
A Twins and Multiple Birth Association (TAMBA) - NCT Joint Report. Maternity Services and
Multiple Births. |